Phillip Andrew Dennis
Chief Medical Officer · 2 filings · Latest: Sep 17, 2026
NovaBridge Biosciences
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NBP | Phillip Andrew Dennis | Chief Medical Officer | Sep 18, 2026 | Sale | $0.71 | 8,209 | $5.8K | 173,427 | |
NBP | Phillip Andrew Dennis | Chief Medical Officer | Sep 17, 2026 | Option Exercise | — | 23,695 | — | 181,636 | |
NBP | Dennis Phillip Andrew | — | Sep 18, 2026 | Proposed Sale | $1.62 | 3,569 | $5.8K | — | |
NBP | Phillip Andrew Dennis | Chief Medical Officer | Jun 18, 2026 | Sale | $0.66 | 8,494 | $5.6K | 157,941 | |
NBP | Phillip Andrew Dennis | Chief Medical Officer | Jun 17, 2026 | Option Exercise | — | 23,695 | — | 166,435 | |
NBP | Dennis Phillip Andrew | — | Mar 18, 2026 | Proposed Sale | $2.79 | 3,638 | $10.2K | — | |
NBP | Dennis Phillip Andrew | — | Dec 18, 2025 | Proposed Sale | $4.23 | 3,431 | $14.5K | — |